Discover why Hims & Hers faces steep corrections amid GLP-1 headwinds and valuation concerns, despite promising FY2024 growth ...

Receiving admilparant, an oral lysophosphatidic acid receptor 1 antagonist, for 26 weeks lowered percent-predicted FVC ...

Loss of pulse detection uses the watch's existing heart rate sensor and an AI algorithm that processes the data. It should ...

Operator Ladies and gentlemen, thank you for standing by, and welcome to the COMPASS Pathways Limited fourth quarter 2024 investor call. [Operator instructions] I will now hand today's call over to ...

Serena Williams is a once-in-a-generation athlete. Even after retiring from professional tennis in 2022, she remains deeply in tune with her body. “My body speaks to me in ways that I don’t know if ...

In the market for a microcurrent device? After two months of testing popular brands like ZIIP, FOREO, NuFACE and Therabody, ...

Manufacturing: As a result of FDA approval of RYONCIL in December 2024, the US$23.0 million provision against the value of inventory manufactured and expensed in prior periods was reversed and is now ...

If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...

The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent skeletal-related events for people with multiple myeloma and other indications ...

Zoetis, the manufacturer behind the vaccine, announced the conditional approval Friday, saying in a news release its scientists had begun updating its existing avian flu vaccine in 2022.

The FDA has approved Samsung Bioepis’ biosimilars of Amgen’s Prolia and Xgeva and granted the therapies interchangeability designation. No information is available on when the drugs will launch or on ...

GOVERNOR Umo Eno of Akwa Ibom State has warned that henceforth no government appointee should issue any Press Statement as they don’t have the right to do so without clearance from the office of ...